Welcome and introduction
Guido Rasi, Executive Director, EMA
Zaide Frias, Head of Human Medicines Evaluation, EMA
- Overview of one-year experience of PRIME eligibility assessments
Robert Hemmings, SAWP chair
- Industry experience and feedback on the eligibility procedure
Aimad Torqui, EFPIA
- Q&A